SCHEMBL753298

SCHEMBL753298

C[C@@H](c1ccc(Oc2ccc(C(=O)O)cc2)cc1Cl)[C@](O)(c1ccc(=O)[nH]c1)C(F)(F)F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.36
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
PTGER4 P35408 1/20 0.35
KMO O15229 1/20 0.34
SCN8A Q9UQD0 2/20 0.33
SCN10A Q9Y5Y9 2/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
CYP2C9 P11712 1/20 0.33
RAB9A P51151 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
RXRG P48443 1/20 0.33
PDE2A O00408 1/20 0.33
CHEK2 O96017 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479901 1.00 GAA (0.36) GAANR1H2NR1H3THRATHRB
SCHEMBL480101 0.88 MCL1 (0.35) NR1H2NR1H3THRATHRBPTGER4
SCHEMBL480778 0.86 SCN8A (0.37) GAASCN8ASCN10APDE2AALDH1A1
SCHEMBL734434 0.82 PTGER4 (0.38) NR1H2NR1H3THRATHRBPTGER4
SCHEMBL15789678 0.82 MCL1 (0.35) NR1H2NR1H3THRATHRBPTGER4
SCHEMBL753038 0.82 PTGER4 (0.38) NR1H2NR1H3THRATHRBPTGER4
SCHEMBL753062 0.80 PDK2 (0.36) GAARXRARXRBPDE2AALDH1A1
SCHEMBL479995 0.80 PDK2 (0.36) GAARXRARXRBPDE2AALDH1A1
SCHEMBL12164056 0.80 BRD4 (0.38) GAANR1H2NR1H3THRATHRB
SCHEMBL474255 0.80 BRD4 (0.38) GAANR1H2NR1H3THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 GAA 3203/4885NR1H2 89/4885NR1H3 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.